Ventas, Inc. $VTR Shares Sold by Presima Securities ULC

Presima Securities ULC decreased its position in Ventas, Inc. (NYSE:VTR) by 17.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 399,359 shares of the real estate investment trust’s stock after selling 86,794 shares during the quarter. Ventas accounts for approximately 7.7% of Presima Securities ULC’s holdings, making the stock its 3rd biggest holding. Presima Securities ULC owned approximately 0.09% of Ventas worth $27,951,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Arbor Capital Management Inc. ADV raised its holdings in shares of Ventas by 0.6% in the third quarter. Arbor Capital Management Inc. ADV now owns 21,716 shares of the real estate investment trust’s stock valued at $1,520,000 after buying an additional 137 shares during the last quarter. Foundations Investment Advisors LLC lifted its position in shares of Ventas by 3.3% during the third quarter. Foundations Investment Advisors LLC now owns 4,447 shares of the real estate investment trust’s stock worth $311,000 after purchasing an additional 144 shares in the last quarter. Ameritas Investment Partners Inc. grew its stake in shares of Ventas by 3.8% during the second quarter. Ameritas Investment Partners Inc. now owns 4,260 shares of the real estate investment trust’s stock valued at $269,000 after purchasing an additional 155 shares during the last quarter. Legacy Wealth Asset Management LLC increased its holdings in shares of Ventas by 3.8% in the second quarter. Legacy Wealth Asset Management LLC now owns 4,335 shares of the real estate investment trust’s stock valued at $274,000 after purchasing an additional 158 shares in the last quarter. Finally, Checchi Capital Advisers LLC raised its position in Ventas by 3.9% in the 3rd quarter. Checchi Capital Advisers LLC now owns 4,603 shares of the real estate investment trust’s stock worth $322,000 after purchasing an additional 174 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on the company. Argus set a $88.00 price objective on Ventas in a research report on Tuesday, February 10th. Royal Bank Of Canada lifted their price objective on Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 10th. Jefferies Financial Group restated a “buy” rating and set a $93.00 target price on shares of Ventas in a report on Monday, December 15th. Cantor Fitzgerald restated an “overweight” rating and issued a $93.00 price objective on shares of Ventas in a research report on Monday, February 9th. Finally, Morgan Stanley set a $90.00 target price on Ventas in a report on Friday, February 13th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Ventas has an average rating of “Moderate Buy” and an average target price of $86.87.

Ventas Stock Performance

NYSE VTR opened at $85.81 on Thursday. The company has a market capitalization of $40.76 billion, a P/E ratio of 158.91, a P/E/G ratio of 2.12 and a beta of 0.77. Ventas, Inc. has a 12-month low of $60.15 and a 12-month high of $87.24. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. The firm has a 50-day moving average price of $78.93 and a two-hundred day moving average price of $74.26.

Ventas (NYSE:VTR) last issued its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The business had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Analysts anticipate that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. This is a boost from Ventas’s previous quarterly dividend of $0.48. Ventas’s payout ratio is currently 355.56%.

Insiders Place Their Bets

In other Ventas news, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the transaction, the executive vice president owned 72,755 shares in the company, valued at approximately $6,184,175. The trade was a 32.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Robert F. Probst sold 29,930 shares of the company’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the transaction, the chief financial officer directly owned 138,434 shares in the company, valued at $10,694,026.50. This represents a 17.78% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 86,106 shares of company stock worth $6,931,397. 0.80% of the stock is currently owned by insiders.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.